Trials / Completed
CompletedNCT05998369
Empowered Relief for Youth
Empowered Relief for Youth: A Feasibility Study of a Pain Management Class for Youth With Pain
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 10 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this pilot study is to examine the feasibility and preliminary efficacy of Empowered Relief for Youth with chronic pain (ER-Y). ER-Y is a single-session pain management class for youth focused on pain science education and teaching self-regulatory skills for pain management based on the evidence-based adult ER class. Feasibility and acceptability of ER-Y will be assessed post-class. Preliminary efficacy will be assessed by administering surveys at baseline, 4-weeks, 8-weeks, and 12-weeks post class.
Detailed description
The current proposed, single-arm, uncontrolled pilot study will determine a) feasibility of ER-Y in youth with chronic pain, b) patients' perceptions and satisfaction of the ER-Y class and c) preliminary efficacy to inform the design of a subsequent randomized controlled trial.
Conditions
- Chronic Pain
- Musculoskeletal Pain
- Fibromyalgia
- Neuropathic Pain
- Complex Regional Pain Syndromes
- Abdominal Pain
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Empowered Relief for Youth | The Empowered Relief for Youth is a 90-minute class that provides pain science education, as well as cognitive, emotional, and physiologic self-regulation skills for youth with chronic pain. Youth will also develop a personalized plan to use the acquired skills daily. Participants will receive an audio file (Relaxation Response) post-class. The class provides patients rapid access to actionable skills for symptom management and pain relief. |
Timeline
- Start date
- 2023-08-09
- Primary completion
- 2024-12-20
- Completion
- 2025-04-01
- First posted
- 2023-08-21
- Last updated
- 2025-10-01
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05998369. Inclusion in this directory is not an endorsement.